Voyageur Pharmaceuticals Stock Net Asset
| VM Stock | CAD 0.05 0.01 9.09% |
Voyageur Pharmaceuticals fundamentals help investors to digest information that contributes to Voyageur Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Voyageur Stock. The fundamental analysis module provides a way to measure Voyageur Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Voyageur Pharmaceuticals stock.
Voyageur | Net Asset |
Voyageur Pharmaceuticals Company Net Asset Analysis
Voyageur Pharmaceuticals' Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Voyageur Pharmaceuticals Net Asset | 2.16 M |
Most of Voyageur Pharmaceuticals' fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Voyageur Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Voyageur Net Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Voyageur Pharmaceuticals is extremely important. It helps to project a fair market value of Voyageur Stock properly, considering its historical fundamentals such as Net Asset. Since Voyageur Pharmaceuticals' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Voyageur Pharmaceuticals' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Voyageur Pharmaceuticals' interrelated accounts and indicators.
Click cells to compare fundamentals
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Voyageur Total Assets
Total Assets |
|
Based on the recorded statements, Voyageur Pharmaceuticals has a Net Asset of 2.16 M. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The net asset for all Canada stocks is notably lower than that of the firm.
Voyageur Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Voyageur Pharmaceuticals' direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Voyageur Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Voyageur Pharmaceuticals by comparing valuation metrics of similar companies.Voyageur Pharmaceuticals is currently under evaluation in net asset category among related companies.
Voyageur Pharmaceuticals Current Valuation Drivers
We derive many important indicators used in calculating different scores of Voyageur Pharmaceuticals from analyzing Voyageur Pharmaceuticals' financial statements. These drivers represent accounts that assess Voyageur Pharmaceuticals' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Voyageur Pharmaceuticals' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 2.8M | 8.5M | 7.5M | 5.2M | 4.7M | 4.1M | |
| Enterprise Value | 3.1M | 7.8M | 7.5M | 5.3M | 4.7M | 4.0M |
Voyageur Fundamentals
| Return On Equity | -0.71 | ||||
| Return On Asset | -0.28 | ||||
| Current Valuation | 6.73 M | ||||
| Shares Outstanding | 138.81 M | ||||
| Shares Owned By Insiders | 10.21 % | ||||
| Number Of Shares Shorted | 9.54 K | ||||
| Price To Book | 6.28 X | ||||
| EBITDA | (1.34 M) | ||||
| Net Income | (1.4 M) | ||||
| Cash And Equivalents | 27.59 K | ||||
| Total Debt | 40 K | ||||
| Debt To Equity | 28.10 % | ||||
| Current Ratio | 0.16 X | ||||
| Book Value Per Share | 0.01 X | ||||
| Cash Flow From Operations | (991.25 K) | ||||
| Short Ratio | 1.26 X | ||||
| Earnings Per Share | (0.01) X | ||||
| Target Price | 0.55 | ||||
| Beta | 0.49 | ||||
| Market Capitalization | 6.94 M | ||||
| Total Asset | 2.16 M | ||||
| Retained Earnings | (9.13 M) | ||||
| Working Capital | (585.25 K) | ||||
| Net Asset | 2.16 M |
About Voyageur Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Voyageur Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Voyageur Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Voyageur Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Voyageur Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for Voyageur Stock analysis
When running Voyageur Pharmaceuticals' price analysis, check to measure Voyageur Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Voyageur Pharmaceuticals is operating at the current time. Most of Voyageur Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Voyageur Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Voyageur Pharmaceuticals' price. Additionally, you may evaluate how the addition of Voyageur Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |